1832 Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-11,079
Closed -$541K – 971
2022
Q4
$541K Sell
11,079
-346,396
-97% -$16M ﹤0.01% 661
2022
Q3
$18.4M Sell
357,475
-54,000
-13% -$3.2M 0.03% 285
2022
Q2
$21.6M Buy
+411,475
New +$28.6M 0.04% 268
2016
Q4
– Sell
-92
Closed -$2K – 751
2016
Q3
$2K Buy
+92
New +$2.4K ﹤0.01% 648
2015
Q3
– Sell
-363,209
Closed -$20.7M – 689
2015
Q2
$20.7M Buy
363,209
+238,566
+191% +$12.2M 0.07% 216
2015
Q1
$6.18M Buy
+124,643
New +$5.83M 0.02% 277

Other funds holding THC

1832 Asset Management's THC Position: Q1 2023 in Review

1832 Asset Management sold out of Tenet Healthcare (THC) in Q1 2023, closing a stake of 11,079 shares — an estimated $541K sold.

1832 Asset Management first reported a position in THC in Q1 2015 and held it in 6 quarters. The position peaked at $21.6M in Q2 2022. 365 funds tracked by Wall St. Rank hold THC as of Q1 2023.

  • 1832 Asset Management reported no remaining Tenet Healthcare position as of Q1 2023 after selling out during the quarter.
  • 1832 Asset Management sold 11,079 Tenet Healthcare shares in Q1 2023, an estimated $541K.
  • 1832 Asset Management first reported a position in Tenet Healthcare in Q1 2015 and held it in 6 quarters.
  • 1832 Asset Management's Tenet Healthcare position peaked at $21.6M in Q2 2022.
  • 365 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2023.

Based on 1832 Asset Management's 13F filing for Q1 2023, filed 12 May 2023.